Ladenburg Thalmann Financial Services’s Health Catalyst HCAT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$16K	Buy	+476	New	+$15.8K	﹤0.01%	4248

Other funds holding HCAT

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

NVPX

Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return

NVPX

Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ladenburg Thalmann Financial Services's HCAT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services opened a new position in Health Catalyst (HCAT) in Q4 2019: 476 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #4248 among its holdings.

88 funds tracked by Wall St. Rank hold HCAT as of Q4 2019.

Ladenburg Thalmann Financial Services held 476 shares of Health Catalyst worth $16K as of Q4 2019.
Health Catalyst was a new Ladenburg Thalmann Financial Services position in Q4 2019.
Health Catalyst made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4248 holding.
88 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.